Examkin

Soru

Zorluk: OrtaPediatric Genetic and Metabolic Disorders

A 66-day-old term neonate is brought to the pediatric emergency department presenting with progressive lethargy, a weak suck, and recurrent emesis over the past 2424 hours. On physical examination, the infant is hypotonic, difficult to arouse, and exhibits deep, rapid respirations. Initial laboratory studies reveal a severe high anion gap metabolic acidosis, significant ketonuria, and a plasma ammonia level of 320μmol/L320 \mu\text{mol/L} (normal: 10−50μmol/L10-50 \mu\text{mol/L}). The clinical picture is highly suspicious for an acute metabolic crisis secondary to an underlying organic acidemia.

Arrange the following management and diagnostic steps in the most appropriate, chronologically prioritized sequence for this patient.

  1. 1Discontinue all enteral feedings to immediately halt exogenous protein intake.
  2. 2Obtain blood and urine for a 'critical sample' (e.g., plasma amino acids, acylcarnitine profile) prior to metabolic alteration.
  3. 3Initiate continuous intravenous fluids with high-concentration dextrose (e.g., 10%10\% dextrose) and lipids.
  4. 4Administer empiric metabolic therapies, including L-carnitine and specific vitamin cofactors.
  5. 5Consult pediatric nephrology for urgent hemodialysis.

Cevap

The correct prioritized sequence for managing an acute neonatal metabolic crisis is: 1) Discontinue all enteral feedings, 2) Draw critical laboratory samples, 3) Initiate high-concentration intravenous dextrose, 4) Administer empiric metabolic therapies (e.g., L-carnitine), and 5) Consult for urgent hemodialysis.
The correct sequence prioritizes preventing further harm (making the patient NPO), securing a diagnosis before the biochemical state is altered by treatment (drawing critical labs), initiating primary life-saving therapy to stop endogenous toxin production (IV dextrose), adding adjunctive clearance medications (L-carnitine), and finally escalating to mechanical clearance (hemodialysis) if the patient deteriorates.

Adım Adım Çözüm

1
Halt exogenous protein intake.
Prevents further absorption and breakdown of dietary amino acids.
Dietary protein directly fuels the production of toxic organic acids and ammonia in affected infants.
2
Obtain the 'critical sample' for diagnosis.
Secures diagnostic metabolic laboratories (acylcarnitines, organic acids).
Intravenous dextrose will rapidly correct the catabolic state, potentially normalizing the biochemical profile and masking the underlying diagnosis if labs are drawn later.
3
Reverse catabolism with intravenous glucose.
Endogenous protein breakdown is stopped.
High-concentration dextrose stimulates insulin release, which drives anabolism and prevents the body from breaking down its own proteins into toxic metabolites.
4
Enhance toxin clearance medically.
Toxic metabolites are conjugated and excreted via urine.
Scavenger medications like L-carnitine bind to toxic acyl groups, forming acylcarnitines that can be safely excreted by the kidneys.
5
Prepare for mechanical toxin removal.
Rapid extracorporeal clearance of severe hyperammonemia.
Required if aggressive medical management is insufficient to prevent irreversible neurologic damage from prolonged hyperammonemia and severe acidosis.

Anahtar Kavram

The acute management of neonatal metabolic crises requires a strict sequence: halting exogenous protein, securing diagnostic 'critical samples', reversing catabolism with high-dose glucose, initiating scavenger therapies, and escalating to hemodialysis if refractory.
Bu soruyu puanla

Konular

Pediatric Genetic and Metabolic Disorders

Bu konudan daha fazla soru